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Functional cognate T cell recognition is mediated via the interaction of a T cell receptor complex with its
pMHC ligand. Adams et al. (2011) in this issue of Immunity provide evidence that docking geometry may
impact 2D binding and T cell activation.The ab T cell receptor (TCR) heterodimer
is similar to an immunoglobulin Fab frag-
ment in overall quaternary structure and
domain conformation, with each subunit
consisting of one variable (V) and one
constant (C) immunoglobulin (Ig) domain
in the extracellular segment (Garcia et al.,
1996). Nevertheless, close inspection re-
veals several important differences: the
ab TCR heterodimer is wider, with a rather
flat binding surface reaching out from
the membrane to match its pMHC ligand
interaction site; it carries a unique 12
amino acid residue insertion in the Cb do-
main, termed the Cb FG loop, reinforcing
the rigid connectivity between Vb and
Cb; and itmanifests a peculiar asymmetric
disposition of Cb relative to Ca to serve as
a dynamic CD3εg docking site (Wang
et al., 1998). The arrangement of the squat
CD3 heterodimers, CD3εg and CD3εd,
lateral to the centrally placed ab hetero-
dimer in a loose confederation of heavily
glycosylated ectodomains fixed by in-
teracting transmembrane segments is
noteworthy (Kim et al., 2009). The CD3z
homodimer, which is virtually without an
ectodomain, also forms part of the trans-
membrane bundle. The CD3 components
each have cytoplasmic tails containing
immunoreceptor tyrosine-based activa-
tion motifs (ITAMs) involved in signaling
upon pMHC ligation, contrasting with
the short ITAM-less a and b cytoplasmic
stumps. These elements collectively com-
prise the TCR complex.
How pMHC ligation of the ab hetero-
dimer initiates signaling via the CD3 com-
ponents in conjunction with Lck kinase-
linked CD4 or CD8 coreceptors is amatter
of intense investigation. That thermo-
dynamic or kinetic parameters of pMHC
binding only loosely correlate with T cell658 Immunity 35, November 23, 2011 ª2011activation outcome and that there are no
discernible ab TCR heterodimer-pMHC
structural changes to distinguish agonist
from nonagonist pMHC ligands (Ding
et al., 1999) has further added to the mys-
tery of this pivotal immune receptor. The
TCR holds the secret of self- versus non-
self-discrimination essential for protective
host immunity in mammals. When TCR
function goes awry, autoimmunity or im-
munodeficiency may follow. Thus, we
need to understand all features of this ex-
traordinary receptor of adaptive T cell
immunity.
In this issue, Adams et al. (2011) com-
pare a crystal structure of the alloreac-
tive 42F3 TCR ab heterodimer in com-
plex with the QL9 nonamer peptide of
2-oxogluterate dehydrogenase bound to
H2-Ld (Ld) with that of the 2C TCR ab
heterodimer bound to the same pMHC.
By using yeast-displayed H2-Ld peptide
libraries whose peptide sequences were
randomized in three different ways in con-
junction with 42F3 tetramers and flow
cytometry sorting, they recovered pep-
tides presented by Ld with TCR binding
sequences divergent from QL9 to varying
degrees (e.g., 3A1 and QL9 are entirely
different peptides, with no single position
identical). In contrast, among the nine
peptide residues, 4B10 diverged from
QL9 at three TCR residues, and 5E8
diverged at three MHC residues. None
of these peptides exists in known pro-
teins. 42F3 complexes with each of these
pMHC ligands were crystallized and
structurally studied. In addition, solution-
binding affinities of recombinant 42F3
with the various pMHCs were determined
by surface plasmon resonance (SPR) (3D),
as well as 2D binding affinity of 42F3
cellular transfectants and their respec-Elsevier Inc.tive capacities, to produce interleukin-2
(IL-2).
The key new findings are 4-fold. First,
3A1-Ld has the highest solution 3D affinity
for 42F3 by SPR equilibrium analysis
(3.9 mM). Second, if the membrane-bound
42F3 is used for 3A1-Ld interaction anal-
ysis in which membrane confinement
properties are in play, this so-called
‘‘2D’’ interaction shows a less-favorable
association. This 2D measurement cor-
relates with lack of IL-2 production of
42F3 T cell transfectants stimulated by
peptide-pulsed antigen-presenting cells
or pMHC oligomers. Third, the TCR-
pMHC docking geometry of 42F3 to
3A1-Ld, the only nonagonist described
here, is divergent from the agonist Ld com-
plexes (QL9, 4B10, and 5E8) with 42F3, as
well as that between 2C and QL9. TCR
42F3 binds diagonally with respect to the
peptide in the agonist pMHC complexes,
as commonly observed in many other
agonist pMHC-TCR complexes, whereas
42F3 aligns more parallel to the peptide
in the nonagonist 3A1 complex. It seems
that the ‘‘nondiagonal’’ docking observed
in the crystal structure may not be com-
patible with the biologically more re-
levant 2D binding. Fourth, even when
there is a similar docking mode among
the same TCR bound to the same MHC
but loaded with different peptides, the
chemistry of interaction is highly diverse.
Different TCR-pMHC complexes can be
more or less Va or Vb centric in con-
served germline contacts. These findings
underscore how plasticity of a single
TCR in binding ligand can diversify
peptide recognition. At the same time,
these data make it abundantly clear that
there are no simple recognition ‘‘rules’’
allowing ab initio prediction of cognate
Figure 1. Superposition of Crystal Structures of 3A1-Ld-42F3 with
QL9-Ld-42F3
Shown here are the a1 and a2 domains of MHC molecule Ld in complex with
the 42F3 TCR ab heterodimer. Only 3A1 peptide (SPLDSLWWI) is shown for
clarity in the peptide-binding groove. TCR 42F3 heterodimeric subunits in
the 3A1-Ld-42F3 complex are in dark green (b subunit) and light green
(a subunit), respectively, and in red (b subunit) and purple (a subunit) in the
QL9-Ld-42F3 complex. The superposition shown is based on the MHC
structure.
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evolved mammalian T cell im-
mune system.
Figure 1 shows the docking
of 42F3 bound to the agonist
QL9-Ld in comparison to that
of the nonstimulatory 3A1-Ld
complex. Only the 3A1 pep-
tide is shown in the MHCI
groove for clarity. The view is
from the side, down the long
axis of the peptide and MHC
helices. It is obvious that 42F3
straddles the groove in the
QL9-Ld complex interacting
with the Ld a1 and a2 helices.
In contrast, when bound to
3A1-Ld, 42F3 docks much
more parallel to the a1 helix,
making few contacts with a2.
The 3A1 peptide points its
two Leu and two Trp side
chains up to the TCR V mod-
ule, providing hydrophobic
contacts for robust TCR inter-
action and readily explaining
the high affinity in solution of
the 42F3-3A1-Ld interaction
and its highest crystal struc-
ture resolution among the
pMHC-TCR complexes. As
stated by the authors, the
register of the two 42F3 Vb
domains, when binding to
QL9-Ld versus 3A1-Ld, ismuch more similar than that of the cor-
responding Va domains.
How can one explain the lack of func-
tional activity of the 3A1-Ld complex? This
is the key question posed by the structural
and functional data. The authors explore
two ideas to address this question. On
the one hand, if a TCR or pMHC were to
form dimers or higher-order oligomers,
then the 3A1 docking topology may be
outside that allowed for a productive
orientation. The notion that the TCR forms
dimers and/or that pMHC forms dimers or
pseudodimers has not been confirmed
structurally. Nonetheless, its existence
has been suggested based on the notion
that TCRs must dimerize in order for sig-
naling to occur in vitro (see below). Alter-
natively, even if the TCR, including its co-
receptor, functions as a unitary signaling
complex, 3A1 docking orientation may
not be allowed, the authors suggest.
These possibilities are predicated on con-
cepts of static binding geometries andcannot readily resolve the enigma. As
pointed out by Adams et al., for example,
2D biophysical parameters manifested by
3A1-Ld-42F3 interaction that fail to acti-
vate 42F3 are equivalent to those param-
eters found to be stimulatory for pMHC-
TCR binding associated with the OT1
TCR. Thus, there is not an absolute 2D
threshold for T cell triggering that has
been uncovered. Likewise, the CD1d-lipid
antigen (aGalCer) recognition by NKT15,
a functional iNKT cell ab TCR, is even
more parallel to the a1 helix of CD1d
than 42F3 to p3A1-Ld (Borg et al., 2007).
iNKT cells may or may not express co-
receptors, but, as Adams suggests, inter-
face specificity is engrafted in the TCR V
domains in the absence of coreceptor
position. Coreceptors themselves do not
bind to the ab heterodimer. In the case
of CD4, for example, in which the ectodo-
main structure is known in its entirety,
TCR ab and CD4 bind to the same
pMHC in a bidentite manner with theirImmunity 35, November 23,membrane-proximal regions
splayed apart by R130 A˚
(Wang et al., 2001).
A dynamic rather than
a static model of TCR ligation
and activation may help to
explain the exciting current
findings. In this regard, sev-
eral groups have recently pro-
vided evidence that physical
force applied to TCR compo-
nents activates T cells (Hus-
son et al., 2011; Kim et al.,
2009; Li et al., 2010). This
activation requires that force
be applied to the TCR com-
plex tangentially and not per-
pendicular to the plane of
the T cell membrane, showing
that the TCR is an anisotropic
mechanosensor (i.e., direc-
tion matters). These findings
were revealed through struc-
tural analysis of the binding of
CD3ε monoclonal antibodies
in conjunction with optical
tweezer experiments. More
importantly, when specific
pMHC-boundbeadswereap-
proximated to the T cell mem-
brane, triggering of T cell acti-
vation occurred only after
tangential force application
(Kim et al., 2009). Such forces
can be exerted by cognatepMHC on APCs through binding the TCR
on an interacting T cell as the T cell moves
when performing immune surveillance
prior to a stop movement signal. The
greater the functional affinity between
pMHC signals and TCR ab heterodimer,
the greater the pull, potentially. The pull
from pMHC most probably causes the
Cb FG loop to push on the upper outer
lobe of CD3ε. How ectodomain qua-
ternary changes alter the TCR complex
transmembrane segments, surrounding
membrane lipid and cytoplasmic tail
structures to transduce signals from out-
side to inside the cell, is a future great
scientific challenge.
Parenthetically, bivalent or multimeric
crosslinking can torque the TCR in a
manner similar to amonomeric interaction
with physical load applied. Thus, the im-
portance of bivalent interaction in medi-
ating TCR activation may not be due to
the requirement for TCR dimerization per
se but rather to torque application. In2011 ª2011 Elsevier Inc. 659
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between TCR ab heterodimer and pMHC
will affect the torque and, hence, physical
force placed on the CD3 subunits. Catch
bonds may form under load, and these
could also change the nature of TCR-
pMHC interaction.
Lastly, unlike antibody Fabs, the TCR
ab and CD3g and CD3d elements are
highly N-linked glycosylated. Glycans
are dynamic, large, and tunable. Those
adducts will affect movement of the TCR
subunits and subsequent signaling. A
study consistent with this notion shows
that TCR functional avidity is altered by
removal of a Ca glycan, for example (Ku-
ball et al., 2009). Given the detailed infor-
mation available from Adams et al., 42F3
may be an ideal system to explore the
effect of these variables onTcell signaling.
It now appears that MHC-restricted TCR660 Immunity 35, November 23, 2011 ª2011recognition is ‘‘restricted’’ by additional
parameters. The structural and functional
studies in the current paper serve well
to underscore the need for further
investigation.REFERENCES
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It is unclear how an effective T cell repertoire is built from a limited array of T cell receptor (TCR) genes. In this
issue of Immunity, Stadinski et al. (2011) demonstrate that TCR variable (V) a chains can indirectly affect
Vb-mediated recognition of the major histocompatibility complex (MHC) molecule.T cell immunity relies on expression of
a single ab T cell receptor (TCR) within
individual T cells. TCRs are antigen recep-
tors that recognize peptide fragments
complexed to either the major histocom-
patibility complex (MHC) class I or class II
glycoproteins (pMHC). TCRs are derived
from random rearrangement of a limited
set of variable (V), diversity (D), and junc-
tional (J) or of the V and J gene segments
found in the TCRb and TCRa gene loci,
respectively. Regions of hypervariability,
called complementary determining re-
gions (CDR) regions, are encoded within
the Va and Vb chain and form the
antigen-binding site. Moreover, the same
set of TCR gene segments are used to
recognize MHC-like molecules such asCD1 family members. During T cell devel-
opment, only those T cell precursors
expressing a TCR capable of interacting
with self-MHC molecules develop into
mature T cells, a process called positive
selection. This process ensures that
T cells become specific for a particular
MHC class with mature CD8+ and CD4+
T cells typically restricted to MHC class I
(MHC I) and class II (MHC II), respectively.
A long-standing paradox has been just
how does the limited set of available
TCR genes within the genome combine
to generate a T cell repertoire diverse
enough to enable recognition of the
seemingly infinite array of highly polymor-
phic MHC alleles and bound peptide
within an outbred population? This ques-tion has dogged the field for decades
and has been compounded by the struc-
tural data, whereby TCRs can bind the
pMHC in a variety of ways (Burrows
et al., 2010). Recent studies have revisited
this central question and determined that
some closely related MHC II-restricted
TCRs, all of which express the same
TCR Vb8.2 gene, make similar contacts
with their cognate pMHC (reviewed by
Marrack et al., 2008). These studies indi-
cate that MHC restriction might be pre-
determined within the germline TCR
V-region repertoire via conserved interac-
tions between CDR2b germline-encoded
residues that direct MHC binding.
As the adage goes, rules are meant
to be broken, and the boundaries
